Use cautionDrug recall · FDA · Published April 30, 2012
Apotex Recalls Eye Drops Due to Particulate Matter
Apotex recalls Dorzolamide HCI/Timolol Maleate eye drops because lots may contain small particulates. Check your bottle lot numbers and expiration date.
“Apotex Recalls Eye Drops Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48913-apotex-inc-recalls-dorzolamide-hci-timolol-maleate-ophthalmic-solution-22. Based on FDA recall #D-1439-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1439-2012%22&limit=1).
The FDA announced on April 30, 2012, that Apotex Inc. is recalling Dorzolamide HCI/Timolol Maleate Ophthalmic Solution due to the presence of particulate matter. The agency classified the recall as Class II.
The recall notification states that lots identified in this recall may contain small particulates. The FDA classified the hazard as Class II.
Context
GovInfoNow's records show Apotex Inc. has 19 other recalls on record since June 25, 2013. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall (Sept. 24, 2019). Other recent recalls of similar products include Apotex Brimonidine/Timolol Eye Drops Recall (March 5, 2026), Clear Eyes Eye Drops Recalled for Sterility Risk (July 29, 2026), and Rohto Cooling Eye Drops Recall (July 14, 2026).
How to tell if you have this one
Look for a 10mL bottle labeled 'Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL'. Check the lot numbers on the packaging; affected lots are JN1060, JN1061, and JN1062. The expiration date on these bottles is June 2012 (Exp 06/12).
Brand
Apotex
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Bottle
Verify if your bottle matches the description and has one of the affected lot numbers (JN1060, JN1061, or JN1062) with an expiration date of 06/12.
Contact Your Pharmacist
If you have the affected product, contact your pharmacist or healthcare provider for instructions on how to return or dispose of the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1439-2012 (April 30, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1439-2012 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.